scholarly journals Patient reported cosmetic outcome after vacuum assisted excision of benign breast lesions: a cross-sectional study

2020 ◽  
Vol 93 (1114) ◽  
pp. 20190994
Author(s):  
Elles M.F. van de Voort ◽  
Taco M.A.L. Klem ◽  
Gerson M. Struik ◽  
Erwin Birnie ◽  
Renata H.J.A. Sinke ◽  
...  
Keyword(s):  
Tumor Size ◽  
Surgical Excision ◽  
Cosmetic Outcome ◽  
Study Patient ◽  
Breast Lesions ◽  
Benign Lesions ◽  
Complete Excision ◽  
Cross Sectional ◽  
Patient Reported ◽  
Benign Breast Lesions

Objective: Better cosmetic outcome after vacuum assisted excision (VAE) compared to surgical excision of benign breast lesions is suggested in previous studies but has never been evaluated with validated outcome measures. In this study, patient reported cosmetic outcome after VAE was evaluated. Methods: Patients who underwent VAE between July 2017 and December 2018 were invited to complete the cosmetic subscale of the Dutch Breast Cancer Treatment Outcome Scale, comparing the treated with the untreated breast. Response mode ranged from 1 (no difference) to 4 (large difference) and cosmetic outcome was calculated as the unweighted mean. Clinical outcomes included: tumor size, number of cores, complications, residual lesions and recurrences. Results: Response rate was 73.4% (47 of 64 patients). Median tumor size was 15 mm (range 5–51 mm) and median number of cores 6.5 (range 1–85), complete excision was confirmed in all but two patients. Mean cosmetic outcome was good (mean score ≤1.75) in 74% of patients and no patients reported a poor cosmetic outcome (mean score >3.25). A hematoma occurred in five patients (one needed aspiration) and a skin rash in one patient, no patients developed an infection or seroma. Conclusion: In this study VAE is safe and effective for tumors up to 5 cm and patient reported cosmetic outcome was good. Patients with benign lesions could benefit from VAE as an alternative for surgical excision. Advances in knowledge: A formal quantitative measurement of cosmetic outcome after vacuum assisted excision for benign breast lesions was still lacking. This study shows that this cosmetic outcome is overall good in benign lesions up to 5 cm.

scholarly journals Vacuum-Assisted Excision, Scarless Solution for Fibroadenoma Breast—A Single-Center Experience

2021 ◽  
Author(s):  
R. Rupa ◽  
Suchana Kushvaha
Keyword(s):  
Surgical Excision ◽  
Excision Biopsy ◽  
Breast Lesions ◽  
Complete Excision ◽  
Single Center Experience ◽  
Percutaneous Removal ◽  
Benign Breast Lesions ◽  
Breast Lumps ◽  
American Society ◽  
Excision Rate

Abstract Background Fibroadenoma is one of the most common benign breast lesions that is frequently surgically excised in breast practice. Aim The aim of this study was to determine the efficacy and safety of ultrasound-guided (USG) vacuum-assisted excision biopsy (VAEB) of fibroadenoma. Settings and Design A retrospective observational study. Methods and Materials A total of 113 patients with 163 fibroadenomas who underwent USG-guided VAEB under local anesthesia with 7G and 10G probes using an Encor Enspire equipment were included in the study. The patients were followed up after 1, 6, and 12 months. The fibroadenomas up to 4 cm were excised as per the U.S. Food and Drug Administration-approved guidelines of the American Society of Surgeons for percutaneous removal of benign breast lesions. Results The percentage of complete excision rate was 98.8% and the most frequent complication encountered was hematoma including immediate and delayed accounting for 3.06%. There were no recurrent lesions in our study. Conclusion USG-guided VAEB of benign breast lumps can be a safe and effective alternative to surgical excision and had better patient satisfaction in terms of efficacy and cosmesis.

scholarly journals Prevalence of c-myc expression in breast lesions associated with microcalcifications detected by routine mammography

2009 ◽  
Vol 127 (2) ◽  
pp. 66-70 ◽  
Author(s):  
Renato Coimbra Mazzini ◽  
Simone Elias ◽  
Afonso Celso Pinto Nazário ◽  
Cláudio Kemp ◽  
Ângela Flávia Logullo
Keyword(s):  
Breast Imaging ◽  
Ductal Carcinoma ◽  
Percutaneous Biopsy ◽  
Screening Mammography ◽  
University Hospital ◽  
Premalignant Lesions ◽  
Breast Lesions ◽  
Benign Lesions ◽  
Cross Sectional ◽  
Malignant Lesions

CONTEXT AND OBJECTIVE: Genetic abnormalities in cell proliferation-regulating genes have been described in premalignant lesions. The aims here were to evaluate c-myc protein expression in non-palpable breast lesions associated with microcalcifications, detected by screening mammography, and to compare these results with histopathological, clinical and epidemiological variables. DESIGN AND SETTING: Analytical cross-sectional study, with retrospective data collection, in a university hospital in São Paulo. METHODS: Seventy-nine female patients who underwent routine mammography between 1998 and 2004 were studied. Lesions classified by the Breast Imaging Reporting and Data System (BI-RADS) as 4 or 5 underwent percutaneous biopsy using a large-core needle. Ninety-eight lesions were studied anatomopathologically. Paraffin blocks properly representing the lesions were selected for immunohistochemical analyses using the streptavidin-biotin-peroxidase technique with monoclonal mouse c-myc antibodies. RESULTS: Among the 98 lesions, 29 (29.6%) contained malignant neoplasia; 40 (40.8%) had a positive immunohistochemical reaction for c-myc. When the groups were divided between lesions without atypias versus atypical lesions plus malignant lesions, 31.03% of the 58 lesions without atypias were positive for c-myc and 55% of the 40 malignant and atypical lesions (P = 0.018). Comparing the atypical lesions with ductal carcinoma in situ versus the benign lesions without atypias, c-myc was present in 51.61% of the 31 atypical lesions and 31.03% of the benign lesions without atypias (P = 0.057). CONCLUSION: C-myc protein was more frequently expressed in atypical and malignant lesions than in benign lesions without atypias. C-myc expression correlated with the presence of atypias (P = 0.018).

scholarly journals Evaluation of diagnostic value of ultrasound and magnetic resonance imaging for malignant and benign breast lesions

2018 ◽  
Vol 2 (5) ◽  
Author(s):  
Yanni Zeng ◽  
Hongwei Zhang ◽  
Jiuxia Zhang ◽  
Yan Yu ◽  
Liangjin Liu
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Statistical Significance ◽  
Diagnostic Value ◽  
Breast Lesions ◽  
Resonance Imaging ◽  
Benign Lesions ◽  
Specificity And Sensitivity ◽  
Treatment Data ◽  
Benign Breast Lesions

[Abstract] Objectives: To investigate diagnostic value of ultrasound and magnetic resonance imaging (MRI) for malignant and benign breast lesions. Methods: Retrospective analysis of treatment data of 48 patients diagnosed with malignant and benign breast lesions in our hospital, collected from December 2017 to November 2018. A total number of 56 breast masses were examined by both ultrasound and MRI, and were compared with postoperative pathological biopsy results. Results: Postoperative pathological biopsy results showed that there were 26 and 30 malignant and benign lesions respectively. Comparison of MRI curve type of malignant and benign lesions showed statistical significance (P<0.05). By comparison with pathological biopsy results, specificity and sensitivity of ultrasound diagnosis were 83.33% (25/30) and 84.61% (22/26) respectively; specificity and sensitivity of MRI diagnosis were 96.66% (29/30) and 92.30% (24/26) respectively. Conclusions: Ultrasonographic examination of malignant and benign breast lesions is straight-forward, simple and inexpensive. Accuracy, specificity and sensitivity of MRI are significantly higher than ultrasound in examining malignant and benign breast lesions, this can reduce misdiagnosis.

scholarly journals Main Symptom that Led to Medical Evaluation and Diagnosis of Vestibular Schwannoma and Patient-Reported Tumor Size: Cross-sectional Study in 1,304 Patients

2018 ◽  
Vol 80 (03) ◽  
pp. 316-322 ◽  
Author(s):  
Maria Peris-Celda ◽  
Christopher S. Graffeo ◽  
Avital Perry ◽  
Panagiotis Kerezoudis ◽  
Nicole M. Tombers ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Tumor Size ◽  
Large Scale ◽  
Demographic Data ◽  
Tumor Biology ◽  
Initial Symptom ◽  
Common Symptom ◽  
Cross Sectional ◽  
Tertiary Referral Center ◽  
Patient Reported

Objectives Although vestibular schwannomas (VS) are known to cause cranial nerve deficits, cerebellar symptoms, and hydrocephalus, the role of these symptoms as the key driver of presentation from the patient's perspective has not been described. Our objective was to survey a large, retrospective VS cohort to document the patient-reported principal initial symptom, and self-reported tumor size, and to study trends in VS patient presentation. Methods Patients diagnosed with VS at our tertiary referral center and belonging to the Acoustic Neuroma Association (ANA) answered a questionnaire between 2015 and 2017. Demographic data, self-reported tumor size, and symptomatology were analyzed. Results 1,304 patients completed the questionnaire. Tumors were diagnosed from 1966 to 2017 at a mean 51.8 years (range: 8–86 years); 66% were female, and 1.1% had confirmed neurofibromatosis type 2 (NF2). Tumor size was reported using a 6-point scale: 0 to 1 cm (22.9%), 1 to 2 cm (28.7%), 2 to 3 cm (20.5%), 3 to 4 cm (10%), greater than 4 cm (7.2%), and unknown (10.6%). Hearing loss was the most common symptom that led to diagnosis (51.5%), followed by dizziness (17%), tinnitus (11.2%), and incidental diagnosis (10.2%); a fraction that has increased significantly in the last decade (p = 0.022). Larger tumors and NF2 were significantly associated with young age (p < 0.001). Conclusion Our large-scale questionnaire-driven review of 1,304 patients confirms that VS presentations are stereotypical, with most individuals recalling hearing loss, dizziness, or tinnitus as their chief complaint. Many tumors were incidentally diagnosed; an expanding population, attributable to increased access to magnetic resonance imaging (MRI). Large tumors were significantly more prevalent among younger patients at diagnosis, excluding NF2 patients, suggesting a more aggressive tumor biology that remains incompletely understood.

Good cosmetic outcome after vacuum assisted excision of benign breast lesions

2020 ◽  
Vol 138 ◽  
pp. S26
Author(s):  
E. Van De Voort ◽  
T. Klem ◽  
G. Struik ◽  
E. Birnie ◽  
R. Sinke ◽  
...  
Keyword(s):  
Cosmetic Outcome ◽  
Breast Lesions ◽  
Good Cosmetic Outcome ◽  
Good Cosmetic ◽  
Benign Breast Lesions

scholarly journals Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.

1993 ◽  
Vol 41 (4) ◽  
pp. 543-553 ◽  
Author(s):  
P S Rudland ◽  
S J Leinster ◽  
J Winstanley ◽  
B Green ◽  
M Atkinson ◽  
...  
Keyword(s):  
Carcinoma In Situ ◽  
Cell Types ◽  
Myoepithelial Cells ◽  
Breast Lesions ◽  
Benign Lesions ◽  
Malignant Breast ◽  
Benign Breast Lesions ◽  
Invasive Carcinomas ◽  
Peripheral Cells

We performed immunocytochemical staining of benign, in situ, and malignant breast disease to identify antigens related to the presence of the major parenchymal cell types of the normal breast. Markers for the epithelial cells, antiserum to epithelial membrane antigen, and three monoclonal antibodies (MAb) to milk-fat globule membranes stained most of the inner cells in benign breast lesions, carcinoma in situ, and invasive carcinomas, but the peripheral cells in benign lesions, as well as in carcinoma in situ, were unstained. MAb to epithelium-specific keratin 18 stained the majority of inner cells in benign breast lesions but comparatively fewer such cells in carcinoma in situ and invasive carcinoma. Markers for the myoepithelial cells, antisera, and MAb to smooth muscle actin and vimentin stained most of the peripheral cells in benign breast lesions and in carcinoma in situ but failed to stain virtually any neoplastic cells in invasive carcinomas. Markers for the basement membrane adjacent to the myoepithelial cells, antiserum, and MAb to laminin and Type IV collagen delineated an intact basement membrane around benign lesions and carcinoma in situ, and fragmented structures in 5-10% of invasive carcinomas; the remaining carcinomas were largely unstained. Markers for both myoepithelial and epithelial cells, keratin MAb PKK2 and LP34, stained most of the inner cells in benign lesions but usually only relatively few malignant cells in carcinoma in situ and invasive carcinomas. Markers for the secretory alveolar cell, MAb to beta- and kappa-casein, stained a few isolated cells in benign lesions, many more inner cells in two such lesions in pregnant females, and none in invasive carcinomas. In conclusion, the myoepithelial cell and, under suitable hormonal conditions, the secretory alveolar cell, are retained in most benign lesions, but they are largely lost in invasive carcinomas.

scholarly journals FNAC of Different Breast Lesions in Subset of Rural Areas of Sindh

2020 ◽  
pp. 10-15
Author(s):  
Santosh Kumar Sidhwani ◽  
Paras Mahesh ◽  
Haresh Chand ◽  
Haider Abbas Mandviwala ◽  
Zahra Saifuddin Rajbhoy ◽  
...  
Keyword(s):  
Rural Areas ◽  
Strong Association ◽  
Cross Sectional Study ◽  
Breast Lesions ◽  
Fibrocystic Disease ◽  
Benign Lesions ◽  
Aspiration Cytology ◽  
Cross Sectional ◽  
Inflammatory Conditions ◽  
Common Malignancy

Background: In the 1970’s the introduction of Fine Need Aspiration Cytology (FNAC) proved to be the key method for examining the nature and malignant potential of many palpable lesions like thyroid, salivary glands and lymphadenopathies. Breast pathologies is one of the entity that can also be diagnosed with FNAC. Breast cancer is the most common malignancy of women with overall 100,000 cases being reported annually around the globe. The most frequent lesion encountered using FNAC in breast is fibro-adenoma followed by fibrocystic disease, breast abscess, chronic inflammatory conditions and suspicious malignant masses. In current cross sectional study we tried to find frequency of different breast lesions by FNAC. Methodology and Results: 649 samples were recruited from the Vital Laboratory Larkana with different pathological lesions of breast during the year 2014 and 2015 by non-probability consecutive sampling. 613 (95%) were females and 32 (5%) were male with mean age of 30.8±12.8 years. Majority of case were of 20-39 years of age (55.8%). Most of the cases were diagnosed with benign lesions (329, 51%) followed by inflammatory lesions (132, 20.5%) and gynecomastia (15, 2.3%). Right breast was more affected (329, 51%). In present study we found a strong association of diagnosis with gender (p =0.000) and age (p =0.000). Conclusion: So in this study it is concluded that large number of females with breast pathologies present with benign lesions like fibro-adenoma at the age of 20-39 years. It is also concluded that in this age group mastitis and abscesses are common due to different risk factors.

scholarly journals Expression of P53, PTEN and S100A4 in invasive ductal breast cancer and the clinical significance

2015 ◽  
Vol 6 (6) ◽  
pp. 43-47 ◽  
Author(s):  
Zhang Gang ◽  
Li Zhong ◽  
Lin Xiao-meng ◽  
Zhang Jun-hua ◽  
Cui Yong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Tumor Size ◽  
Breast Lesions ◽  
Clinical Grade ◽  
Invasive Ductal Breast Cancer ◽  
Node Metastasis ◽  
Ductal Breast Cancer ◽  
Benign Breast Lesions

Objective: To investigate the expression level of P53, PTEN and S100A4 in invasive ductal breast cancer and the clinical significance. Methods: SP immunohistochemical and Western blot analysis were used to detect the expression of P53, PTEN and S100A4 protein in invasive ductal breast cancer, adjacent tissues and benign breast lesions. The results were aimed to explore the correlation of p53, PTEN, S100A4 and analyze the relationship between indicators and clinical pathology. Results: Immunohistochemical results showed that the positive rates of p53 and S100A4 in invasive ductal breast cancer were 47.69% and 56.92%, which were significantly higher than that in benign breast lesions (16.00%, 22.00%) (p<0.05); The positive rates of PTEN in invasive ductal breast cancer was 24.62%, which were significantly lower than that in benign breast lesions (52.00%) (p<0.05); The expression of p53 was negatively correlated with PTEN in invasive ductal breast cancer (p<0.05). Western blot results revealed that the relative expression levels of p53, PTEN and S100A4 protein in invasive ductal breast cancer were 0.967±0.066, 0.785±0.044, 1.065±0.073, which were significant difference with that in benign breast lesions (0.549±0.032, 1.245±0.059, 0.370±0.065) (p<0.05); The expression of p53 has correlation with histological differentiating degree and lymph node metastasis (p<0.05), but it was irrelevant to the age, tumor size and clinical grade (p>0.05). The expression of S100A4 has correlation with clinical grade and lymph node metastasis (p<0.05), but no association with the age, tumor size and histological differentiating degree was observed in this study (p>0.05). The expressions of PTEN has correlation with lymph node metastasis p<0.05, but no association with the age, tumor size, clinical grade and histological differentiating degree was noted in our study (p>0.05). Conclusion: Expression of P53, PTEN and S100A4 can be expected to be taken as to the prognosis biomarkers of breast cancer and potential targets for new and effective treatment strategies for breast cancer.DOI: http://dx.doi.org/10.3126/ajms.v6i6.12599 Asian Journal of Medical Sciences Vol.6(6) 2015 43-47

scholarly journals Effects of Neoadjuvant Chemotherapy on Benign Breast Lesions Compared to Cancers: Should an Additional Lesion on Magnetic Resonance Imaging Responding Similar to Cancer after Neoadjuvant Chemotherapy be Viewed with Suspicion?

2016 ◽  
Vol 6 ◽  
pp. 39
Author(s):  
Rebecca Leddy ◽  
Abid Irshad ◽  
Lara Hewett ◽  
Heather Collins ◽  
Frank Vento ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Neoadjuvant Chemotherapy ◽  
Breast Lesions ◽  
Resonance Imaging ◽  
Benign Lesions ◽  
Mean Size ◽  
Malignant Lesions ◽  
The Mean ◽  
Benign Breast Lesions

Purpose: Determining the effects of neoadjuvant chemotherapy (NAC) on benign breast lesions and to evaluate their response in comparison to breast cancers. Methods: A retrospective analysis performed on breast cancer patients between 2008 and 2014 to identify patients who had a pre- and post-NAC magnetic resonance imaging (MRI) and biopsy-proven benign lesions. Pre- and post-NAC size and intensity of enhancement of benign lesions and cancers were measured. Breast glandularity and background enhancement were graded. A 2 × 2 repeated measures ANOVAs and Sidak post hoc tests were conducted for multiple comparisons. Paired t-tests were conducted to examine changes over time, and two-tailed P values were reported. Results: The effects of NAC in 38 cancers were compared to the effects of NAC in 47 benign lesions in these patients. From pre- to post-NAC, the mean size (cm) of malignant lesions on MRI decreased from 4.09 (±standard deviation [SD] 2.51) to 1.54 (±SD 2.32), (P < 0.001); the mean size (cm) of benign lesions decreased from 0.83 (±SD 0.54 cm) to 0.28 (±SD 0.51), (P < 0.001). Both benign and malignant lesions decreased in size after NAC, the size reduction in malignant lesions was significantly greater than benign lesions. From pre- to post-NAC, the mean lesion enhancement of the malignant lesions (scale 1–4) decreased from 3.43 (±SD 0.80) to 1.02 (±SD 1.34); the mean lesion enhancement of benign lesions decreased from 2.96 (±SD 1.04) to 0.98 (±SD 1.51). For both benign and malignant lesions, there was a significant overall reduction in enhancement after NAC from moderate at pre-NAC to minimal at post-NAC, P < 0.001. There was no overall difference in the enhancement of cancers (mean = 2.22, SD = 0.79) versus benign lesions (mean = 1.97, SD = 1.08), (P = 0.23). There was no significant change in glandularity from pretherapy (mean = 3.11, SD = 0.84) to posttherapy (mean = 3.13, SD = 0.82), P < 0.001. Conclusion: Similar to cancers, benign breast lesions also show a significant decrease in size and enhancement after NAC; however, the decrease in size is less compared to cancers.

Sign in / Sign up

Export Citation Format

Share Document